Rep. Lisa C. McClain Sells Off Shares of Humana Inc. (NYSE:HUM)

Representative Lisa C. McClain (R-Michigan) recently sold shares of Humana Inc. (NYSE:HUM). In a filing disclosed on November 21st, the Representative disclosed that they had sold between $1,001 and $15,000 in Humana stock on October 31st.

Representative Lisa C. McClain also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Ciena (NYSE:CIEN) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Alibaba Group (NYSE:BABA) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Coherent (NYSE:COHR) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Clorox (NYSE:CLX) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Northern Trust (NASDAQ:NTRS) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Honda Motor (NYSE:HMC) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Home BancShares (NYSE:HOMB) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Five Below (NASDAQ:FIVE) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Pure Storage (NYSE:PSTG) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of BHP Group (NYSE:BHP) on 10/31/2025.

Humana Stock Up 3.3%

HUM stock traded up $7.85 during midday trading on Wednesday, reaching $245.73. The company had a trading volume of 1,948,342 shares, compared to its average volume of 1,763,011. The company has a 50 day moving average of $264.19 and a two-hundred day moving average of $256.86. The company has a market capitalization of $29.55 billion, a P/E ratio of 18.86, a PEG ratio of 1.71 and a beta of 0.42. Humana Inc. has a 1 year low of $206.87 and a 1 year high of $315.35. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.95 by $0.29. Humana had a return on equity of 13.67% and a net margin of 1.28%.The business had revenue of $32.65 billion during the quarter, compared to analyst estimates of $31.99 billion. During the same period last year, the company earned $4.16 earnings per share. Humana’s quarterly revenue was up 11.1% compared to the same quarter last year. On average, equities research analysts expect that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Friday, December 26th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.4%. The ex-dividend date is Friday, December 26th. Humana’s dividend payout ratio is currently 33.18%.

Institutional Trading of Humana

Several institutional investors have recently modified their holdings of HUM. Keyes Stange & Wooten Wealth Management LLC acquired a new position in Humana in the third quarter valued at about $201,000. CIBC Bancorp USA Inc. bought a new position in shares of Humana in the third quarter valued at approximately $4,321,000. Achmea Investment Management B.V. boosted its holdings in shares of Humana by 7.6% in the 3rd quarter. Achmea Investment Management B.V. now owns 11,860 shares of the insurance provider’s stock worth $3,086,000 after acquiring an additional 841 shares in the last quarter. Centaurus Financial Inc. bought a new stake in Humana during the 3rd quarter worth approximately $1,197,000. Finally, Asset Dedication LLC increased its holdings in Humana by 454.1% during the 3rd quarter. Asset Dedication LLC now owns 1,219 shares of the insurance provider’s stock valued at $317,000 after purchasing an additional 999 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently commented on HUM. Barclays lowered their price target on Humana from $245.00 to $234.00 and set an “equal weight” rating for the company in a research note on Tuesday. Wall Street Zen cut shares of Humana from a “buy” rating to a “hold” rating in a report on Saturday, August 2nd. Piper Sandler lowered their target price on shares of Humana from $288.00 to $272.00 and set a “neutral” rating on the stock in a research report on Thursday, July 31st. Morgan Stanley reduced their price target on Humana from $290.00 to $277.00 and set an “equal weight” rating for the company in a research report on Thursday, July 31st. Finally, Sanford C. Bernstein increased their price objective on Humana from $269.00 to $341.00 and gave the company an “outperform” rating in a report on Friday, September 5th. Eight analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, Humana currently has an average rating of “Hold” and an average target price of $295.94.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan’s 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027.

McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan’s 9th Congressional District. She declared candidacy for the 2026 election.

Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor’s degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.